Medicinal product name Relvar Ellipta
Pharmaceutical form Inhalation powder, pre-dispensed
Strength 184 μg/22 μg 
Information from the MAH on shortages No information on expected shortages
Availability of medicinal product
Product No.Package sizeWholesalers' stock state
EU/1/13/886/005 KZSN30: 1 × 30 Is available
Legal status Rx Prescription (Pr.)
KZS NHS Reimbursed medicines
 Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
ATC code R03AK10 Drugs for obstructive airway diseases

Important notice

Additional information regarding the use for persons aged 75+

If used as "DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES"
SubstanceClassComment
Fluticasoni furoasASuitable for older persons. Take into account possible systemic adverse effects. Take interactions into account.
VilanterolumASuitable for older persons. Potentiates sympathomimetic effects. May cause hypokalaemia.

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Is available (according to the information provided by wholesalers)
(2328 containers)
Tamro, Berlin-Chemie/Menarini Baltic, Olainfarm, Recipe Plus, Oribalt Rīga, Magnum Medical, Euroaptieka N30: 1 × 30
(184 µg/22 µg)
Aluminium blister 61.87 
KZS*
EU/1/13/886/005  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
* Indication about medicine on the List of state reimbursed medicines is just informative. Source of the information is the National Health Service. For details please visit the NHS website.

Registration information

Marketing authorisation No. EU/1/13/886/005
Date of authorisation Nov 13, 2013
Marketing authorisation holder, country GlaxoSmithKline (Ireland) Limited, Ireland